Bioqube Ventures
Uilstraat 30
3500 Hasselt
BE
Bioqube Ventures
Foundation date
21/01/2016
Sector
#InvestorSubsector
Bioqube ventures is a specialist life sciences investment firm that focuses on early-stage investments. We cut cost, accelerate business and bring value by linking three key components: access to capital, specialized infrastructure and expertise. Our partnership with Johnson & Johnson Innovation – JLINX, is the embodiment of our mission: a multifaceted approach that enables early-stage healthcare companies to reach their full potential in a cost effective and time efficient way.
Upcoming events
All events-
1804 '24
Anglonordic Life Science Conference 2024
Event by: BioPartner -
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
2304 '24
BioTrinity 2024
Event by: OBN
Latest news
More news-
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
Wednesday March 27th 2024
Read more
-
InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline
Tuesday March 26th 2024
Read more
-
Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy
Monday March 25th 2024
Read more
Jobs
More jobs-
28/03/24
Flemish Brabant
Post-doc position – Structural Bioinformatics of protein interactions
Permanent
VIB -
-
More info?
Ellen Telleir
Communication Coordinator